Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Hanmi Science synthesizes new EZH1/2 inhibitors

Sep. 10, 2020

Insilico Medicine identifies new TNIK/MAP4K4 inhibitors

Sep. 10, 2020

New RET inhibitors identified at Sichuan Kelun-Biotech Biopharmaceutical

Sep. 10, 2020

CLR-131 shows clinically meaningful ORR in refractory multiple myeloma in phase II CLOVER-1 study

Sep. 10, 2020

Zion initiates phase I study in U.S. with ZN-A-1041

Sep. 9, 2020

Inhibitory decoy gene created to inhibit Galpha-q for uveal melanoma treatment

Sep. 8, 2020

Amplia receives ethics committee clearance for phase I trial of FAK inhibitor AMP-945

Sep. 8, 2020

Shenzhen Targetrx Biotechnology discovers RET inhibitors

Sep. 8, 2020

New candidate breast cancer risk gene identified

Sep. 8, 2020

Dracen Pharmaceuticals begins first-in-human study of DRP-104

Sep. 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...